DoD Amyotrophic Lateral Sclerosis Therapeutic Idea Award

Archived

Defense Health Agency Contracting Activity - DHACA

Description

The Therapeutic Idea Award is designed to promote new ideas that are still in the early stages of development with the potential to yield highly impactful data and new avenues of investigation for novel therapeutics for ALS treatment. This mechanism supports conceptually innovative, high-risk/high-reward research that could ultimately lead to critical discoveries or major advancement in ALS therapeutics. Proposed research projects should include a well-formulated, testable hypothesis based on strong scientific rationale that holds translational potential to improve ALS treatment and/or advances a novel treatment modality. Projects that focus primarily on investigating the pathophysiology of ALS are outside the scientific scope of this mechanism.

Who can apply

  • Unrestricted

Contact

301-682-5507; help@eBRAP.org
help@eBRAP.org

Key dates & funding
  • PostedApr 1, 2014
  • ClosesAug 20, 2014
  • Program funding$1,280,000
  • Expected awards2
  • CFDA12.420

Pro insight

Edit and export this grant’s proposal template, plus deadline reminders, similar-grant suggestions, and funder history — all available with Pro.

Unlock with Pro